A 50-year-old male patient with no significant family history presents to the clinic for a wellness check.
According to the current American Cancer Society guidelines, which cancer screening test should he undergo at this visit?
Smoking cessation.
Cervical cancer screening.
Colorectal cancer screening.
Mammogram.
The Correct Answer is C
Choice A rationale
Smoking cessation is a vital health promotion intervention but it is not classified as a cancer screening test. Screening tests involve specific diagnostic procedures to detect the presence of malignancy in asymptomatic individuals. While counseling against tobacco use significantly reduces the risk of multiple cancers, the guidelines for a wellness check specifically prioritize physical tests like colonoscopies or stool based assays for a fifty year old patient to identify early stages of neoplasia.
Choice B rationale
Cervical cancer screening is specifically indicated for individuals with a cervix, typically women between the ages of twenty one and sixty five. This male patient does not possess the anatomical structures required for a Papanicolaou test or human papillomavirus screening. Therefore, this intervention is clinically irrelevant for his demographic. Screening protocols are strictly gender and age specific to ensure that resources are directed toward the biological risks present in the specific patient population being evaluated.
Choice C rationale
The American Cancer Society recommends that adults at average risk begin regular colorectal cancer screening at age forty five. This fifty year old male falls directly into the high priority age group for these tests, which include options like colonoscopy, CT colonography, or fecal immunochemical tests. Detecting polyps or early stage adenocarcinoma in the colon significantly improves survival rates. At this age, the prevalence of colorectal lesions increases, making this the most appropriate screening for his visit.
Choice D rationale
Mammography is the primary screening tool used for the early detection of breast cancer, primarily in women starting at age forty to forty five. While men can develop breast cancer, it is extremely rare and routine screening is not recommended for males without a strong family history or known genetic mutations like BRCA2. Since this patient has no significant family history, a mammogram is not indicated according to standard preventive health guidelines for his gender and age.
Choice A rationale
Smoking cessation is a vital health promotion intervention but it is not classified as a cancer screening test. Screening tests involve specific diagnostic procedures to detect the presence of malignancy in asymptomatic individuals. While counseling against tobacco use significantly reduces the risk of multiple cancers, the guidelines for a wellness check specifically prioritize physical tests like colonoscopies or stool based assays for a fifty year old patient to identify early stages of neoplasia.
Choice B rationale
Cervical cancer screening is specifically indicated for individuals with a cervix, typically women between the ages of twenty one and sixty five. This male patient does not possess the anatomical structures required for a Papanicolaou test or human papillomavirus screening. Therefore, this intervention is clinically irrelevant for his demographic. Screening protocols are strictly gender and age specific to ensure that resources are directed toward the biological risks present in the specific patient population being evaluated.
Choice C rationale
The American Cancer Society recommends that adults at average risk begin regular colorectal cancer screening at age forty five. This fifty year old male falls directly into the high priority age group for these tests, which include options like colonoscopy, CT colonography, or fecal immunochemical tests. Detecting polyps or early stage adenocarcinoma in the colon significantly improves survival rates. At this age, the prevalence of colorectal lesions increases, making this the most appropriate screening for his visit.
Choice D rationale
Mammography is the primary screening tool used for the early detection of breast cancer, primarily in women starting at age forty to forty five. While men can develop breast cancer, it is extremely rare and routine screening is not recommended for males without a strong family history or known genetic mutations like BRCA2. Since this patient has no significant family history, a mammogram is not indicated according to standard preventive health guidelines for his gender and age.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","C"]
Explanation
Choice A rationale
The T component of the TNM staging system is scientifically designed to evaluate the primary tumor site. This assessment includes measuring the size of the tumor in centimeters and determining the degree of invasion into adjacent anatomical structures. For example, a higher T numerical value suggests a larger tumor or one that has penetrated deeper into the surrounding tissues. This information is critical for clinicians to understand the local burden of the disease and plan surgical interventions.
Choice B rationale
The N component specifically assesses the involvement of regional lymph nodes by the cancer cells. This part of the staging system documents whether the malignancy has migrated from the primary site to nearby nodes, which serve as common pathways for cancer spread. A classification of N0 indicates no nodal involvement, while N1, N2, or N3 reflect increasing numbers or distances of affected nodes. Identifying nodal status is essential for determining the necessity of adjuvant therapies like radiation or chemotherapy.
Choice C rationale
The M component stands for metastasis and is used to identify whether the cancer has spread to distant organs or tissues far from the primary tumor. This is a binary or tiered assessment where M0 indicates no distant spread and M1 indicates the presence of distant metastases. Understanding the metastatic status is perhaps the most vital part of staging, as it fundamentally shifts the treatment goal from curative intent to palliative care or systemic management of the disease.
Choice D rationale
While the TNM staging system provides a detailed snapshot of the cancer's anatomical extent at the time of diagnosis, it is not primarily used to measure the response to initial treatment. Assessing treatment response typically involves follow-up imaging, biopsy, or tumor marker analysis to compare the status of the cancer before and after therapy. The TNM system is a diagnostic and prognostic tool utilized to establish a baseline and determine the most appropriate initial clinical management strategy. .
Correct Answer is A
Explanation
Choice A rationale
This antimalarial medication is a cornerstone in managing systemic lupus erythematosus by inhibiting the stimulation of toll-like receptors and reducing the production of inflammatory cytokines. It is primarily used to control skin rashes, joint pain, and fatigue while significantly reducing the frequency of disease flares. Clinical evidence suggests it also provides a long-term survival benefit and prevents organ damage accrual in patients with chronic autoimmune responses.
Choice B rationale
This monoclonal antibody specifically targets B-lymphocyte stimulator proteins to reduce the activity of B cells contributing to the autoimmune response in lupus. While it is an approved adjunct treatment for active, autoantibody-positive systemic lupus erythematosus, it is generally reserved for patients who do not respond adequately to standard therapies. It is not considered the most common first-line systemic agent compared to the widespread and foundational use of antimalarial drugs in this population.
Choice C rationale
Nonsteroidal anti-inflammatory drugs are frequently utilized in lupus management to alleviate musculoskeletal pain, pleurisy, and fever by inhibiting cyclooxygenase enzymes and prostaglandin synthesis. However, these medications only provide symptomatic relief for minor manifestations and do not modify the underlying disease course or prevent major organ exacerbations. Their use is often limited by potential side effects including gastrointestinal irritation, renal impairment, and increased cardiovascular risk in patients with systemic inflammation.
Choice D rationale
This folate antimetabolite acts as a potent immunosuppressant by interfering with DNA synthesis and cellular proliferation, particularly in rapidly dividing immune cells. It is often employed in lupus cases involving significant arthritis or skin disease that remains refractory to antimalarials. While effective for controlling inflammation, it carries a higher risk profile than first-line agents, necessitating frequent monitoring of liver function tests and complete blood counts to detect potential hepatotoxicity or bone marrow suppression.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.